Whalegun
Lobbying

Farmaceuticalrx of Pa's latest lobbying report covers Q4 2024, at $30K. Its first report covers Q4 2022; the issues it reports most are Banking and Health Issues.

Farmaceuticalrx of Pa

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Farmaceuticalrx of Pa lobbying by quarter
Farmaceuticalrx of Pa lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$50K1
Q2 2023$50K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$30K1
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Banking$215K · 9 reports
  • Health issues$215K · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)9 reports
  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports

Firms it paid

Firm
Ballard Partners$430K9 quarters

Former officials lobbying for it

Former position
DANIEL MCFAULLegislative Director to U.S. Representative Joe Scarborough; Chief of Staff to U.S. Representatives Jeff Miller and Matt GaetzQ4 2024
TOLA THOMPSONCommunications Director and Senior Legislative Assistant to U.S. Representative Carrie Meek (1993-2002); Chief of Staff to U.S. Representative Al Lawson (2017-2021)Q3 2024

Lobbying reports

Filed by
25/01/21for Q4 2024Ballard Partners$30K
24/10/17for Q3 2024Ballard Partners$50K
24/07/20for Q2 2024Ballard Partners$50K
24/04/19for Q1 2024Ballard Partners$50K
24/01/17for Q4 2023Ballard Partners$50K
23/10/19for Q3 2023Ballard Partners$50K
23/07/18for Q2 2023Ballard Partners$50K
23/04/19for Q1 2023Ballard Partners$50K
23/01/19for Q4 2022Ballard Partners$50K